The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 14, 2026

Filed:

Apr. 29, 2021
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Peter Kwong, Washington, DC (US);

Guillaume Stewart-Jones, Cambridge, MA (US);

Jason Gorman, New York, NY (US);

Li Ou, Potomac, MD (US);

Tongqing Zhou, Boyds, MD (US);

Baoshan Zhang, Bethesda, MD (US);

Wing-Pui Kong, Germantown, MD (US);

Yaroslav Tsybovsky, Brunswick, MD (US);

John Mascola, Rockville, MD (US);

Peter Collins, Kensington, MD (US);

Ursula Buchholz, Silver Spring, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 39/155 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/155 (2013.01); A61P 31/14 (2018.01); C07K 2299/00 (2013.01); C07K 2319/03 (2013.01); C07K 2319/50 (2013.01); C12N 2760/18322 (2013.01); C12N 2760/18334 (2013.01); C12N 2760/18371 (2013.01);
Abstract

Metapneumovirus (HMPV) F ectodomain trimers stabilized in a prefusion or postfusion conformation, nucleic acid molecules and vectors encoding these proteins, and methods of their use and production are disclosed. In several embodiments, the HMPV F ectodomain trimers and/or nucleic acid molecules can be used to generate an immune response to HMPV in a subject. In additional embodiments, the therapeutically effective amount of the HMPV F ectodomain trimers and/or nucleic acid molecules can be administered to a subject in a method of treating or preventing HMPV infection.


Find Patent Forward Citations

Loading…